Navigation Links
Coherus annonce que CHS-1420 (Adalimumab biosimilaire expérimental) est conforme aux critères d'efficacité principaux dans une étude clinique pharmacocinétique pivot
Date:8/15/2014

indre cette étape-jalon clinique valide encore plus la plate-forme de développement de Coherus et démontre notre capacité à développer des biosimilaires dans notre portefeuille », déclare Denny Lanfear, PDG de Coherus.

À propos de Coherus BioSciences, Inc.

Coherus est une entreprise plate-forme de médicaments biologiques de phase tardive centrée sur le marché biosimilaire mondial. Basée dans la région de la baie de San Francisco et composée par un groupe de vétérans de l'industrie avec des dizaines d'années d'expérience dans la création sociétés biologiques pionnières, Coherus a pour objectif de devenir un leader mondial du marché des biosimilaires en utilisant la somme des expertises de son équipe dans des domaines clés tels que la science des processus, la caractérisation analytique, la production de protéines et le développement clinique réglementaire. Les partenariats mondiaux de commercialisation de Coherus font intervenir des entreprises biopharmaceutiques mondiales en Europe, en Asie et en Amérique latine.

Les biosimilaires doivent remplacer les médicaments biologiques de marque actuels en vue de traiter une gamme élargie de maladies chroniques et mettant souvent en jeu le pronostic vital, avec le potentiel de réduire les coûts et de renforcer l'accès des patients. Pour de plus amples informations, veuillez consulter www.coherus.com.

Contact Coherus BioSciences 

Beth Jimison
+1-650-649-3526
bjimison@coherus.com

Logo - http://photos.prnewswire.com/prnh/20120507/SF01
'/>"/>

SOURCE Coherus BioSciences
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Coherus anuncia que CHS-1420 cumple con los objetivos primarios en el ensayo clínico farmacocinética pivote
2. Coherus Announces CHS-1420 (Investigational Adalimumab Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study
3. Coherus anuncia início do estudo Fase 3 do CHS-0214 (Biossimilar Investigativo do Etanercept) em psoríase crônica em placas (RaPsOdy)
4. Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy)
5. Coherus Biosciences Invited to Present at 2014 J.P. Morgan Annual Healthcare Conference
6. Coherus Biosciences als Präsentator zur J.P. Morgan Annual Healthcare Conference 2014 eingeladen
7. Coherus anuncia que CHS-0214 (biosimilar etanercept propuesto) supera punto final primario en decisivo estudio clínico farmacocinético
8. Coherus Announces CHS-0214 (Proposed Etanercept Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study
9. Annonce dun forum sur « La conception dappareils médicaux »
10. Blue Belt Technologies annonce que le Golden Jubilee National Hospital a réalisé la première opération NavioPFS darthroplastie unicondylaire du genou
11. Valeant Pharmaceuticals Annonces New $1.5 Billion Securites Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014 NxStage Medical, Inc. (NASDAQ: ... dialysis products, announced today that the U.S. Food ... One™ to perform hemodialysis overnight while the patient ... hemodialysis. NxStage,s® System One is the first and ... this indication. Home nocturnal hemodialysis ...
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... the "US Self-monitoring Blood Glucose Market" report ... This market insight focuses on the ... the United States . Reimbursement analysis and ... product analyses for more than 73 SMBG meters have ...
(Date:12/22/2014)... 2014 Research and Markets ( ... "Investment Analysis of the US Medical Device ... http://photos.prnewswire.com/prnh/20130307/600769 ... device sector identifies the key trends and rationale ... and mergers and acquisitions. The study ...
Breaking Medicine Technology:NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3US Self-monitoring Blood Glucose Market 2Investment Analysis of the US Medical Device Sector 2
... Pa., Feb. 27, 2012 Auxilium Pharmaceuticals, Inc. (Nasdaq: ... participate in the 2012 Cowen Healthcare Conference to be ... in Boston.  Mr. Jim Fickenscher, Chief Financial Officer, is ... its product pipeline at 9:20 a.m. ET on Tuesday, ...
... (Pink Sheets: TROV.PK), a developer of trans-renal molecular diagnostics, ... to expand its business development activities and monetize the ... "Trovagene owns a significant portfolio of molecular diagnostic intellectual ... applications. While the company will focus its internal R&D ...
Cached Medicine Technology:Auxilium Pharmaceuticals to Present at the 2012 Cowen Healthcare Conference 2Auxilium Pharmaceuticals to Present at the 2012 Cowen Healthcare Conference 3Auxilium Pharmaceuticals to Present at the 2012 Cowen Healthcare Conference 4Trovagene Expands Business Development Efforts Through a Partnership with Leomics Associates, Inc. 2Trovagene Expands Business Development Efforts Through a Partnership with Leomics Associates, Inc. 3
(Date:12/25/2014)... BambooFlooringChina.com sells many bamboo products and the business is ... company announces big discounts on its bamboo mats , ... is the world’s leader in bamboo flooring. According to ... 20, 2015. , The bamboo mats are made from ... All the bamboo strips for the mats are boiled ...
(Date:12/25/2014)... December 25, 2014 Recently, LunaDress.co.uk has updated its ... and related accessories. Now, all of the models at LunaDress.co.uk come ... a groom lifts the wedding veil can turn out to be ... charm. A wedding veil can always bring surprise to a wedding. ... on how to choose veils for a big day . ...
(Date:12/25/2014)... (HealthDay News) -- Overeating is common during the holidays, but ... an expert says. "Don,t arrive at a party hungry. ... know you,ll be attending a party, but deprivation leads to ... at Northern Westchester Hospital in Mount Kisco, N.Y., said in ... during the day and even to have a snack before ...
(Date:12/25/2014)... AngelWeddingDress.com tries its best to translate the experience ... business has introduced its new collection of 2015 prom ... The new prom outfits are guaranteed to contain the ... are specially designed for 2015. Anyone who wants to ... its website before Jan. 26, 2015, the deadline of ...
(Date:12/25/2014)... California (PRWEB) December 25, 2014 Plugin ... of ProFire 5k. A fully customizable business presentation tool ... , “Adding the ProFire 5k business tool, users can ... Christina Austin, CEO of Pixel Film Studios. “ProFire 5k ... and style to add professionalism to a presentation” , ...
Breaking Medicine News(10 mins):Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
... Conseco, Inc. (NYSE:,CNO) today announced that it ... Partners II, L.P. to increase its percentage ownership ... response letter sent to Steel Partners by Conseco ... insurance companies help protect working American,families and seniors ...
... CRGN ) today announced that it had received ... regained compliance with the,requirements for continued listing on the ... In a letter dated January 28, 2008, NASDAQ ... 28, 2008 to regain compliance with,Marketplace Rule 4450(a)(5) by ...
... PORTLAND, Ore. New research from the Oregon Health ... may bring a wellspring of hope to many patients. ... kinds of DNA abnormalities that can occur in a ... with different kinds of acral and mucosal melanomas, which ...
... cochlear implant patients seen by Indiana University School of ... that cochlear implants in both ears significantly improves quality ... that the cost of the second implant is offset ... in the May issue of the journal Otolaryngology-Head and ...
... used to prepare a powerful cancer-killing agent may be ... the natural product attacks, according to findings published in ... Chemistry. , Building on their earlier research into neocarzinostatin, ... University of Wisconsin, Madison discovered that one of the ...
... goes to the Senate, SACRAMENTO, Calif., May ... in just as many years, the pro-assisted,suicide group ... 2747,(Berg/Levine). This new bill represents a strategy change ... their future efforts. As part of a,coordinated national ...
Cached Medicine News:Health News:Conseco Declines Proposal from Steel Partners II, L.P.; Proposal Would Reduce Conseco's Financial Flexibility and Potentially Disadvantage Other Shareholders 2Health News:Conseco Declines Proposal from Steel Partners II, L.P.; Proposal Would Reduce Conseco's Financial Flexibility and Potentially Disadvantage Other Shareholders 3Health News:Conseco Declines Proposal from Steel Partners II, L.P.; Proposal Would Reduce Conseco's Financial Flexibility and Potentially Disadvantage Other Shareholders 4Health News:CuraGen Corporation Regains NASDAQ Listing Compliance 2Health News:CuraGen Corporation Regains NASDAQ Listing Compliance 3Health News:OHSU Cancer Instutute researchers find abnormalities in gene for melanoma 2Health News:Bilateral cochlear implants: A case when 2 are definitely superior to 1 2Health News:Enzyme may hold key to improved targeting of cancer-fighting drugs 2Health News:Californians Against Assisted Suicide - Controversial Bill, AB 2747 Narrowly Passes Assembly 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: